Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study

Mycophenolate Mofetil or Intravenous Cyclophosphamide for Lupus Nephritis With Poor Kidney Function: A Subgroup Analysis of the Aspreva Lupus Management Study

(2013) Michael Walsh et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids

(2013) Marie B Condon et al.   ANNALS OF THE RHEUMATIC DISEASES

Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response

(2013) T. Jonsdottir et al.   RHEUMATOLOGY

Induction and Maintenance Treatment of Proliferative Lupus Nephritis: A Meta-analysis of Randomized Controlled Trials

(2012) Lorna K. Henderson et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Rituximab versus oral cyclophosphamide for treatment of relapses of proliferative lupus nephritis: a clinical observational study

(2012) Gabriella Moroni et al.   ANNALS OF THE RHEUMATIC DISEASES

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

(2012) George K Bertsias et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and Safety of Mycophenolate Mofetil versus Cyclophosphamide for Induction Therapy of Lupus Nephritis

(2012) Lin-Lin Liu et al.   DRUGS

Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis

(2012) Marc Weidenbusch et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts

(2011) Cándido Díaz-Lagares et al.   AUTOIMMUNITY REVIEWS

Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy

(2011) D. Roccatello et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Early treatment with rituximab in newly diagnosed systemic lupus erythematosus patients: a steroid-sparing regimen

(2011) A. N. Ezeonyeji et al.   RHEUMATOLOGY

Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial

(2010) F. A. Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry

(2010) Benjamin Terrier et al.   ARTHRITIS AND RHEUMATISM

Rituximab Therapy in Lupus Nephritis: Current Clinical Evidence

(2010) Manuel Ramos-Casals et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis

(2010) YH Lee et al.   LUPUS

Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

(2010) John H. Stone et al.   NEW ENGLAND JOURNAL OF MEDICINE

The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide

(2009) F A Houssiau et al.   ANNALS OF THE RHEUMATIC DISEASES

A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at university college london hospital: The first fifty patients

(2009) Tim Y.-T. Lu et al.   ARTHRITIS AND RHEUMATISM

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial

(2009) Joan T. Merrill et al.   ARTHRITIS AND RHEUMATISM

Rituximab in Severe Lupus Nephritis: Early B-Cell Depletion Affects Long-Term Renal Outcome

(2009) C. Melander et al.   Clinical Journal of the American Society of Nephrology

Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases

(2009) M Ramos-Casals et al.   LUPUS

Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study

(2009) John N. Boletis et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Rituximab is an effective treatment for lupus nephritis and allows a reduction in maintenance steroids

(2009) R. Pepper et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Is combination rituximab with cyclophosphamide better than rituximab alone in the treatment of lupus nephritis?

(2009) E. K. Li et al.   RHEUMATOLOGY

Complete Remission of Lupus Nephritis With Rituximab and Steroids for Induction and Rituximab Alone for Maintenance Therapy

(2008) Laurent Camous et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Mycophenolate mofetil in the treatment of lupus nephritis – 7 years on

(2008) TM Chan   LUPUS

Effects of mycophenolate mofetil for patients with crescentic lupus nephritis

(2008) ZHENG TANG et al.   NEPHROLOGY